depositphotos.com
Nov 20, 2025, 13:57
Can AI Predict Thrombotic Recurrence in Antiphospholipid Syndrome?
RPTH Journal shared a post on LinkedIn:
“Can AI predict thrombotic recurrence in antiphospholipid syndrome?
A new study explores how machine learning could transform risk stratification and anticoagulation strategies for patients with APS.
Curious about the key predictors and the algorithm that outperformed the rest?
Title: Machine learning for predicting thrombotic recurrence in antiphospholipid syndrome
Authors: Ana Marco-Rico, Ihosvany Fernández-Bello, Jorge Mateo-Sotos, Pascual Marco-Vera
Read the full article here”
Stay updated with Hemostasis Today.
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory
-
Oct 13, 2026, 01:51Berenice Villegas: The Role of Morphologic Evaluation in Body Fluid Differential Analysis
-
Oct 13, 2026, 01:44Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
-
Oct 13, 2026, 01:34Nagesh Ramesh: Donating Blood for International Plasma Awareness Week
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE